Improving the Yield of Xenocoumacin 1 Enabled by In Situ Product Removal
Sign Up to like & getrecommendations! Published in 2020 at "ACS Omega"
DOI: 10.1021/acsomega.0c02357
Abstract: Xenocoumacin 1 (Xcn1), a major antimicrobial compound produced by Xenorhabdus nematophila CB6, has great potential to be developed into a novel biofungicide. However, its low yield in the producing cells has limited its possible commercial… read more here.
Keywords: product removal; yield; xenocoumacin; situ product ... See more keywords